National Control of Tuberculosis: Does Primary Health Care System Play a Crucial Role in the Fight Against Tuberculosis?

Türkkanı, Mustafa Hamidullah; Özdemir, Tarkan; Özdilekcan, Çiğdem; Akkuş, İbrahim Halil

doi:10.5152/turkthoracj.2018.092

Cited by 2 publications

(3 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A health-care service delivery model was used to identify the problem in DR-TB diagnosis. The study revealed that the rate of sputum examination in Turkey was around 71.6% and the DST was around 25.8% [16]. However, these statements reveal more extensive problems:I admit that performing the microscopic examination is exhausting as we have to look at and count the number of bacilli in continuous high exposure of light.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Artificial intelligence in overcoming rifampicin resistant-screening challenges in Indonesia: a qualitative study on the user experience of CUHAS-ROBUST

Herman

Sirichokchatchawan

Nantasenamat

et al. 2021

JHR

View full text Add to dashboard Cite

PurposeThe Chulalongkorn-Hasanuddin Rifampicin-Resistant Tuberculosis Screening Tool (CUHAS-ROBUST) is an artificial intelligence–based (AI–based) application for rifampicin-resistant tuberculosis (RR-TB) screening. This study aims to elaborate on the drug-resistant TB (DR-TB) problem and the impact of CUHAS-ROBUST implementation on RR-TB screening.Design/methodology/approachA qualitative approach with content analysis was performed from September 2020 to October 2020. Medical staff from the primary care center were invited online for application trials and in-depth video call interviews. Transcripts were derived as a data source. An inductive thematic data saturation technique was conducted. Descriptive data of participants, user experience and the impact on the health service were summarizedFindingsA total of 33 participants were selected from eight major islands in Indonesia. The findings show that DR-TB is a new threat, and its diagnosis faces obstacles particularly prolonged waiting time and inevitable delayed treatment. Despite overcoming the RR-TB screening problems with fast prediction, the dubious screening performance, and the reliability of data collection for input parameters were the main concerns of CUHAS-ROBUST. Nevertheless, this application increases the confidence in decision-making, promotes medical procedure compliance, active surveillance and enhancing a low-cost screening approach.Originality/valueThe CUHAS-ROBUST achieved its purpose as a tool for clinical decision-making in RR-TB screening. Moreover, this study demonstrates AI roles in enhancing health-care quality and boost public health efforts against tuberculosis.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Diagnosis Of Drug-resistant Tuberculosis Is Time-consuming Costly and Inaccessiblementioning

confidence: 96%

Artificial intelligence in overcoming rifampicin resistant-screening challenges in Indonesia: a qualitative study on the user experience of CUHAS-ROBUST

Herman

Sirichokchatchawan

Nantasenamat

et al. 2021

JHR

View full text Add to dashboard Cite

show abstract

“…The issue with DR-TB diagnosis was identified using a healthcare service delivery model. According to a report, the rate of sputum inspection in Turkey was approximately 71.6 % and the DST was approximately 25.8 % (185). These findings indicate more serious problems.…”

Section: Diagnosis Of Dr-tb Is Time-consuming Costly and Inaccessiblementioning

confidence: 99%

Cost effectiveness of oral health care program implementation in primary school in Bangkok, Thailand

Herman¹

View full text Add to dashboard Cite

Background: Diagnosis of Pulmonary Rifampicin Resistant Tuberculosis (RR-TB) with the Drug-Susceptibility Test (DST) is costly and time-consuming, and the GeneXpert for rapid diagnosis is not widely available in Indonesia. This study aims to develop an Artificial Neural Network model and evaluate the deployed model performance for RR-TB screening. Methods: A cross-sectional study involved suspected RR-TB patients with complete sputum Lowenstein Jensen DST (reference) and 19 clinical, laboratory, and radiology parameter results, retrieved from medical records in hospitals under the Faculty of Medicine, Hasanuddin University Indonesia, from January 2015-December 2019. The Artificial Neural Network (ANN) models were built along with other classifiers. The model was tested on participants recruited from January 2020-October 2020 and deployed into CUHAS-ROBUST (index test) application. Sensitivity, specificity, and accuracy were obtained for assessment. A qualitative approach with content analysis was performed from September 2020 to October 2020. Medical staff from the primary care center were invited online for application trials and in-depth video call interviews. Transcripts were derived as a data source. An inductive thematic data saturation technique was conducted. Descriptive data of participants, user experience, and impact on the health service was summarized. Cost-effectiveness analysis of direct cost was made using the data of 330 participants who underwent Genexpert and Model, confirmed by DST. The Quality Adjusted Life years of TB being untreated was used as the approximation of the undiagnosed TB (acute morbidity, chronic morbidity, and mortality). The Incremental Cost-Effectiveness Ratio (ICER) was calculated. Results: A total of 487 participants (32 Multidrug-Resistant/MDR 57 RR-TB, 398 drug-sensitive) were recruited for model building and 157 participants (23 MDR and 21 RR) in prospective testing. The ANN full model yields 88% (95% CI 85-91) accuracy, 84% (95% CI 76-89) sensitivity, and 90% specificity (95% CI 86-93). This ANN model outperforms other classifiers and selected for the CUHAS-ROBUST application. A total of 33 participants (an average of 33.12 years old) were recruited from all parts of Indonesia. The findings show that DR-TB is a new threat, and its diagnosis faces obstacles particularly prolonged waiting time and inevitable delayed treatment. Despite overcoming the RR-TB screening problems with fast prediction, the dubious screening performance, and the reliability of data collection for input parameters were the main concerns of CUHAS-ROBUST. Nevertheless, this application increases confidence in decision making, promotes medical procedure compliance, active surveillance, and enhancing a low-cost screening approach. A cost-effectiveness analysis was made. The ICER Mortality value is -3601.706137. The ICER Acute Morbidity value is -17225.55 and The ICER Chronic Morbidity value is -825.391. The very minimum sensitivity of the model to not surpass the willingness to pay (WTP) of 100 USD per QALYs gained is 80.6%. The ideal prevalence of RR-TB according to the screening using model is 14.8% to 23.3%. Using the average cost, the results still consistent, showing the model as the dominant intervention Conclusions: Despite showing lower sensitivity than global GeneXpert results. The ANN-CUHAS ROBUST outperforms other AI classifier models, and by deploying it into the application, the health staff can utilize the tool for screening purposes particularly at the primary care level. Moreover, this study demonstrates AI's roles in enhancing healthcare quality and boost public health efforts against tuberculosis. The advantage of this device is cost-effective although it should need a bigger test expansion.

show abstract

National Control of Tuberculosis: Does Primary Health Care System Play a Crucial Role in the Fight Against Tuberculosis?

Cited by 2 publications

References 5 publications

Artificial intelligence in overcoming rifampicin resistant-screening challenges in Indonesia: a qualitative study on the user experience of CUHAS-ROBUST

Artificial intelligence in overcoming rifampicin resistant-screening challenges in Indonesia: a qualitative study on the user experience of CUHAS-ROBUST

Cost effectiveness of oral health care program implementation in primary school in Bangkok, Thailand

Contact Info

Product

Resources

About